COMPANY PROFILE · /proscia
P
Proscia
Proscia develops digital pathology software and AI-powered image analysis tools for cancer diagnosis and drug development. Its Concentriq platform integrates whole-slide imaging with machine learning for pathology labs and pharma companies.
Fresh · 5d ago
Latest valuation
—
Annual Recurring Revenue
—
Headcount
—
Funding total
$130M+
OVERVIEW
Raised $50M Series D in early 2025, bringing total to $130M+. Platform serves 16 of top 20 pharma companies; 22,000+ patients/day on Concentriq. Strategic partnership with Ibex Medical for AI-powered prostate cancer diagnostics.
Status
active
Tier
master-list
Profitability
—
Pricing
enterprise
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0
No products catalogued yet. Press Refresh above to ask the research agent.
TEAM · 0 key people
No people linked.
SOURCES · 0 cited
No citations stored yet. Run the research agent to attach per-claim sources.